- Ovarian cancer was the third most common gynecological cancer globally in 2020.
- High-grade serous ovarian carcinoma is the most common type of ovarian cancer.
- As there are currently no reliable screening tests for ovarian cancer, almost all cases are diagnosed at the advanced stage, lowering a woman’s survival rate.
- Researchers from the Keck School of Medicine of USC have developed a new blood test for the detection of early-stage ovarian cancer.
- The test can reportedly distinguish between cancerous and benign pelvic masses with up to 91% accuracy.
In 2020, ovarian cancer was the
If detected at an early stage, the
However, almost all cases of this type of ovarian cancer are diagnosed at an advanced stage, which lowers the 10-year survival rate to 15%. That is because there is currently
Now, researchers from the Keck School of Medicine of the University of Southern California (USC) are trying to change that by developing a new blood test for the detection of early-stage ovarian cancer that can distinguish between cancerous and benign pelvic masses with up to 91% accuracy — a higher rate than that of other tests currently available.
This study recently appeared in the journal Clinical Cancer Research.
Ovarian cancer begins in the
Early symptoms of ovarian cancer — such as bloating, abdominal pain, and frequent urination — are very similar to the types of symptoms a woman has during her menstrual cycle, urinary tract infection, or irritable bowel syndrome.
For this reason, ovarian cancer is
Read the full article here